What’s your plan for capitalizing on the growing profit potential of every calf?
When seasons change, tremendous potential is waiting to be realized in pastures across the country. Capitalize on the growing profit potential of every calf. Optimize your ROI by keeping your animals and operation healthy.
VaccinateStart with vaccination against one of the leading causes of profit loss: pathogens that cause bovine respiratory disease (BRD) and other key diseases.
Strategic TreatmentRecognize the importance of strategically using trusted anti-infectives to mitigate the impact of BRD.
Accelerate GainIncrease growth efficiency with one of the most profitable management tools available: implanting.
The temptation is there to take these calves right off the cow and send them to the sale barn and cash in. We know that weaning and preconditioning for around 45 days on the farm or ranch of origin is the most important factor in ensuring a calf’s health as it moves through the production system. During those 45 days, calves tend to gain weight at a rate of up to 2 lbs. per day, leading to more profits for the producer.¹
— Brett Terhaar, DVM, Elanco beef technical consultant
Preparing Calves for the Feedlot
When preparing calves for the feedlot, shortcuts can take away from future performance and profits. Dr. Terhaar shares how a well-executed plan can help put your herd and operation one step ahead.
Prevent respiratory challenges with Elanco vaccines
Elanco vaccines protect against leading challenges such as BRD so cattle stay healthy and productive no matter where they go next.
Our vaccine lineup incorporates advanced technology resulting in effective, flexible and safe tools for protection against challenging viral and bacterial diseases.
Titanium®
Tough on respiratory and reproductive pathogens. Easy on cattle. Ideal for your bottom line.
NUPLURA® PH+
Fast, smooth, powerful and convenient protection against Bovine Respiratory Disease (BRD).
Vira Shield®
As a research-proven, safe and powerful line of inactivated vaccines, Vira Shield provides comprehensive protection against up to 13 respiratory and reproductive pathogens.
Confidently treat BRD when it strikes
Management and vaccination for BRD is a must. But antibiotics are still necessary for treatment when you can’t control stressors like weather or transportation that leave cattle vulnerable to disease. The Elanco anti-infective portfolio provides unique options with leading brands offering distinctive modes of action that can be customized into an effective and efficient approach.
Pradalexᵀᴹ (pradofloxacin injection)
Pradalex is an innovative third generation fluoroquinolone antibiotic for the treatment of bovine respiratory disease (BRD).
Baytril® 100 (enrofloxacin)
Baytril 100 is a proven tool for BRD treatment and control in beef and non-lactating dairy.
Micotil® (tilmicosin injection)
A proven, long-lasting BRD treatment that offers an effective, flexible dose range for both metaphylaxis and individual pull-and-treat therapy.
Increxxa™ (tulathromycin injection)
The macrolide antibiotic you can trust to help your cattle breathe easier while balancing your budget.
Tylan® Injection (tylosin injection)
Treats BRD in high-risk cattle as well as treats foot rot in beef and non-lactating dairy cattle.
Additional Resources
Earn more for your beef calves this fall
With a well-executed plan, you can ensure you’re staying one step ahead and keeping both your animals and your operation healthy. Read more on how to maximize calf profitability this fall.
Podcast: Capture added value for your calves
Animal husbandry can make or break your profitability. Pre-conditioning is a key step in ensuring calves maintain their health during weaning. Elanco technical consultants Drs. Terhaar, Falkner and Ayers join the NCBA Cattleman's Call podcast to share their tips.
Are you prepared for calving season?
You can never prepare too much or too early for calving. Check out these tips to see how you can support your cows throughout pregnancy to enhance the health and productivity of your herd.
Sign up to stay One Step Ahead
Get the latest in updates, news and offers from Elanco delivered directly to your inbox.
The label contains complete use information, including cautions and warnings. Always read, understand and follow the label, and use directions.
Micotil
Indications: Micotil is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni. It is indicated for the control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica.
Important Safety Information (ISI)
Before using Micotil 300, it is important to read the entire product insert, including the boxed human warning. For full prescribing information call 1 888 545 5973 or visit www.elancolabels.com/us/micotil-300.
HUMAN WARNING: Not for human use. Injection of this drug in humans has been associated with fatalities. Keep out of reach of children. Administer only with a tube-fed safety syringe. Do not use in automatically powered syringes, single-use syringes, or other delivery devices. Exercise extreme caution to avoid accidental self-injection. In case of human injection, consult a physician immediately and apply ice or cold pack to injection site while avoiding direct contact with the skin. Emergency medical telephone numbers are 1-800-722-0987 or 1-800-428-4441. Avoid contact with skin, eyes, or mucous membranes.
Micotil is available only by prescription. Micotil must be used with the quick-fit connector and tube-fed safety syringe included to avoid accidental self-injection. Contact Elanco or your distributor for this equipment if needed. For subcutaneous injection in cattle and sheep only; do not administer intravenously. Injection of this antibiotic has been shown to be fatal in swine and non-human primates and may be fatal in horses, goats, and other species. Not for use in use in lactating dairy cattle 20 months of age or older. Use in lactating dairy cattle or sheep may cause milk residues. Injection site swelling and inflammation, lameness, collapse, anaphylaxis/anaphylactoid reactions, decreased food and water consumption, and death have been reported in cattle. Micotil has a pre-slaughter withdrawal time of 42 days. See package insert for full prescribing information.
Baytril 100
Indications: Single-Dose Therapy: Baytril 100 is indicated for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of BRD in beef and non-lactating dairy cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and M. bovis.
Multiple-Day Therapy: Baytril 100 is indicated for the treatment of BRD associated with M. haemolytica, P. multocida and H. somni in beef and non-lactating dairy cattle.
Important Safety Information (ISI)
BAYTRIL 100 CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian and prohibits the extra-label use of this drug in food-producing animals.
Not for human use. Keep out of reach of children. Avoid contact with eyes and skin. Individuals with a history of hypersensitivity to quinolones should avoid this product. Not for use in female dairy cattle 20 months of age or older, including dry dairy cows, and veal calves; a withdrawal period has not been established for this product in pre-ruminating calves. Quinolone-class drugs should be used with caution in animals with known or suspected Central Nervous System (CNS) disorders. Baytril 100 has a pre-slaughter withdrawal time of 28 days for cattle. See package insert for additional safety information.
Increxxa
Indications: Beef and Non-Lactating Dairy Cattle: Increxxa is indicated for the treatment of bovine respiratory disease (BRD) and control of respiratory disease in cattle at high risk of developing BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis; for the treatment of infectious bovine keratoconjunctivitis (IBK) associated with Moraxella bovis; and for the treatment of bovine foot rot (interdigital necrobacillosis) associated with Fusobacterium necrophorum and Porphyromonas levii.
Suckling Calves, Dairy Calves and Veal Calves: Increxxa is indicated for the treatment of BRD associated with M. haemolytica, P. multocida, H. somni, and M. bovis.
Important Safety Information (ISI)
Increxxa is available only by prescription. Not for human use. Keep out of reach of children. Do not use in animals previously found to be hypersensitive to the drug. Not for use in chickens or turkeys. Do not use in female dairy cattle 20 months of age or older, including dry dairy cows. Injection site reactions and anaphylaxis/anaphylactoid reactions have been reported in cattle. Increxxa has a pre-slaughter withdrawal time of 18 days for cattle. See package insert for full prescribing information.
Pradalex
Indications: Pradalex is indicated for the treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in cattle intended for slaughter (beef calves 2 months of age and older, growing beef steers, growing beef heifers, and beef bulls intended for slaughter), and in cattle intended for breeding less than 1 year of age (replacement beef and dairy heifers less than 1 year of age and beef and dairy bulls less than 1 year of age). Not for use in cattle intended for breeding 1 year of age and older (replacement beef and dairy heifers 1 year of age and older, beef and dairy bulls 1 year of age and older, and beef and dairy cows), beef calves less than 2 months of age, dairy calves, and veal calves.
Important Safety Information (ISI)
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian and prohibits the extra-label use of this drug in food-producing animals. To ensure responsible antimicrobial drug use, use of pradofloxacin should be limited to treatment of bovine respiratory disease (BRD) in cattle only after consideration of other non-fluoroquinolone therapeutic options.
Not for use in humans. Keep out of reach of children. Avoid contact with eyes and skin. Individuals with a history of hypersensitivity to quinolones should avoid this product. Not for use in animals intended for breeding greater than 1 year of age. Not for use in beef calves less than 2 months of age, dairy calves and veal calves; a withdrawal period has not been established for this product in pre-ruminating calves. Quinolones should be used with caution in animals with known or suspected central nervous system (CNS) disorders. Mild to moderate inflammatory changes of the injection site may be seen in cattle treated with Pradalex. Pradalex has a pre-slaughter withdrawal time of 4 days for cattle. See package insert for additional safety information.
Tylan Injection
Indications: In Beef Cattle and Non-lactating Dairy Cattle: Tylan 200 Injection is indicated for use in the treatment of bovine respiratory complex (shipping fever, pneumonia) usually associated with Pasteurella multocida and Arcanobacterium pyogenes; foot rot (necrotic pododermatitis) and calf diphtheria caused by Fusobacterium necorphorum and metritis caused by Arcanobacterium pyogenes.
Important Safety Information (ISI)
CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
WARNING: NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN.
Label: Tylan 200 Injection 250 mL http://elancolabels.com/us/tylan-200-injection-250-ml
Label: Tylan 200 Injection 500mL http://elancolabels.com/us/tylan-200-injection-500ml
Do not use Titanium® BRSV 3, Titanium® 3 LP, Titanium® 3, Titanium® IBR LP and Titanium® IBR in pregnant cows or in calves nursing pregnant cows. Abortions may result.
Increxxa, Micotil, Nuplura, Pradalex, Titanium, Tylan, Vira Shield, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.
Baytril is sold by Elanco or its affiliates and is not a Bayer product. The Baytril trademark is owned by Bayer and used under license.
